(A) Endovascular coiling admissions overall, monthly volumes before and during the COVID-19 pandemic, and (B) surgical clipping admissions overall and monthly volumes before and during the COVID-19 pandemic
(A) | |||||||||
N | Overall volume | Monthly volume* | |||||||
n1 | n2 | Change | P vaue | N | Before COVID-19 | During COVID-19 | P value | ||
% (95% CI) | Adjusted mean (SE) | ||||||||
Overall | 152 | 3464 | 3374 | −2.6 (−3.2 to −2.1) | 0.276 | 166 | 2.06 (0.44) | 2.02 (0.43) | 0.518 |
Hospital endovascular coiling volume stratified by prepandemic aSAH volume†† | |||||||||
Low | 42 | 183 | 231 | 26.2 (20.4 to 33.1) | 0.019 | 47 | 0.35 (0.09) | 0.45 (0.10) | 0.058 |
Int. | 54 | 842 | 813 | −3.4 (−4.9 to −2.4) | 0.476 | 56 | 1.28 (0.15) | 1.26 (0.15) | 0.783 |
High | 50 | 2240 | 2135 | −4.7 (−5.7 to −3.9) | 0.112 | 55 | 4.13 (0.82) | 3.97 (0.81) | 0.269 |
Hospital endovascular coiling volume stratified by hospital COVID-19 volume‡‡ | |||||||||
Low | 45 | 851 | 870 | 2.2 (1.4 to 3.5) | 0.647 | 49 | 1.44 (0.46) | 1.48 (0.45) | 0.729 |
Int. | 42 | 798 | 828 | 3.8 (2.7 to 5.3) | 0.457 | 45 | 1.35 (0.45) | 1.41 (0.44) | 0.495 |
High | 44 | 1047 | 990 | −5.4 (−7.0 to −4.2) | 0.207 | 48 | 2.12 (0.78) | 2.0 (0.78) | 0.273 |
(B) | |||||||||
N | Overall volume | Monthly volume* | |||||||
n1 | n2 | Change | P value | N | Before COVID-19 | During COVID-19 | P value | ||
% (95% CI) | Adjusted mean (SE) | ||||||||
Overall | 140 | 1848 | 1676 | −9.3 (−10.7 to −8.1) | 0.004 | 151 | 1.29 (0.42) | 1.18 (0.43) | 0.067 |
Hospital clipping volume stratified by prepandemic aSAH volume§§ | |||||||||
Low | 40 | 91 | 101 | 11.0 (6.1 to 19.1) | 0.471 | 45 | 0.13 (0.05) | 0.14 (0.06) | 0.616 |
Int. | 50 | 350 | 368 | 5.1 (3.3 to 8.0) | 0.502 | 51 | 0.61 (0.11) | 0.63 (0.12) | 0.826 |
High | 47 | 1392 | 1202 | −13.6 (−15.6 to −12.0) | 0.0002 | 51 | 2.65 (0.90) | 2.32 (0.93) | 0.034 |
Hospital clipping volume stratified by hospital COVID-19 volume ¶¶ | |||||||||
Low | 45 | 650 | 672 | 3.4 (2.2 to 5.1) | 0.545 | 47 | 0.40 (0.68) | 0.44 (0.72) | 0.655 |
Int | 37 | 411 | 387 | −5.8 (−8.5 to −4.0) | 0.396 | 41 | 0.68 (0.46) | 0.63 (0.48) | 0.308 |
High | 42 | 519 | 401 | −22.7 (−26.5 to −19.3) | 0.0001 | 44 | 1.16 (0.29) | 0.89 (0.23) | 0.102 |
*The monthly volume analysis is adjusted for the date of peak COVID-19 volume for each country, the start date of the second wave, and the continent.
†P value: low versus int.=N/A, low versus high=N/A, int. versus high=0.115.
‡P value: low versus int.=0.056, low versus high=N/A, int. versus high=N/A.
§P value: low versus int.=0.040, low versus high=N/A, int. versus high=N/A.
¶P value: low versus int.=N/A, low versus high=N/A, int. versus high≤0.0001.
aSAH, aneurysmal subarachnoid haemorrhage; int., intermediate; n1, number of admissions during 12 months before COVID-19 pandemic; n2, number of admissions during 12 months of COVID-19 pandemic; N/A, not applicable; n, number of hospitals; SAH, subarachnoid haemorrhage.